| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1025516766 |
| P356 | DOI | 10.1186/1476-4598-7-15 |
| P932 | PMC publication ID | 2246151 |
| P698 | PubMed publication ID | 18221536 |
| P5875 | ResearchGate publication ID | 5629363 |
| P2093 | author name string | Ashley G Rivenbark | |
| Wendell D Jones | |||
| William B Coleman | |||
| J Devon Roll | |||
| P2860 | cites work | The Hallmarks of Cancer | Q221226 |
| Bisulfite genomic sequencing: systematic investigation of critical experimental parameters | Q24555629 | ||
| CpG island methylator phenotype in colorectal cancer | Q24672170 | ||
| Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction | Q25938986 | ||
| Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications | Q27860709 | ||
| Molecular portraits of human breast tumours | Q28032461 | ||
| Lipocalins and cancer | Q28142718 | ||
| Cadherin switch in tumor progression | Q28262569 | ||
| Proteomics-based validation of genomic data: applications in colorectal cancer diagnosis. | Q31042613 | ||
| Characterization of a side population of cancer cells from human gastrointestinal system | Q33225639 | ||
| The molecular portraits of breast tumors are conserved across microarray platforms | Q33241398 | ||
| DNA methylation and gastrointestinal malignancies: functional consequences and clinical implications | Q34076536 | ||
| A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer | Q34126908 | ||
| Association of the CpG island methylator phenotype with family history of cancer in patients with colorectal cancer | Q34225610 | ||
| DNA methylation of RASSF1A, HIN‐1, RAR‐β, Cyclin D2 and Twist in in situ and invasive lobular breast carcinoma | Q34274795 | ||
| Lack of CpG island methylator phenotype defines a clinical subtype of T-cell acute lymphoblastic leukemia associated with good prognosis | Q34455183 | ||
| Epigenetic silencing of the tumor suppressor cystatin M occurs during breast cancer progression. | Q34557790 | ||
| DNA methylation-dependent silencing of CST6 in human breast cancer cell lines | Q34574105 | ||
| Classification and risk stratification of invasive breast carcinomas using a real-time quantitative RT-PCR assay | Q35012779 | ||
| Distinct methylated profiles in Helicobacter pylori dependent and independent gastric MALT lymphomas | Q35595610 | ||
| Primary ovarian carcinomas display multiple methylator phenotypes involving known tumor suppressor genes | Q35746441 | ||
| Dormant hypermethylated tumour suppressor genes: questions and answers | Q36005954 | ||
| Towards novel anti-cancer strategies based on cystatin function | Q36127269 | ||
| Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma | Q36338003 | ||
| DNA methylation and gene silencing in cancer | Q36338042 | ||
| Epigenetic information and estrogen receptor alpha expression in breast cancer | Q36364262 | ||
| The role of DNA methylation in cancer development | Q36595035 | ||
| High expression of the DNA methyltransferase gene characterizes human neoplastic cells and progression stages of colon cancer | Q37487997 | ||
| Increased cytosine DNA-methyltransferase activity is target-cell-specific and an early event in lung cancer | Q37628234 | ||
| Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study | Q39605778 | ||
| DNA methylation-dependent epigenetic regulation of gene expression in MCF-7 breast cancer cells | Q40052862 | ||
| E-cadherin gene promoter hypermethylation in H. pylori-induced enlarged fold gastritis | Q40087337 | ||
| Effect of combined therapy with low-dose 5-aza-2'-deoxycytidine and irinotecan on colon cancer cell line HCT-15. | Q40188797 | ||
| Clinical evaluation of E-cadherin expression and its regulation mechanism in epithelial ovarian cancer | Q40257906 | ||
| Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers | Q40310725 | ||
| CpG island methylator phenotype is a strong determinant of poor prognosis in neuroblastomas. | Q40459667 | ||
| A novel role for carcinoembryonic antigen-related cell adhesion molecule 6 as a determinant of gemcitabine chemoresistance in pancreatic adenocarcinoma cells | Q40550114 | ||
| Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal cancer cell lines. | Q40582817 | ||
| Inhibition of DNA methylation by 5-aza-2'-deoxycytidine suppresses the growth of human tumor cell lines | Q41072124 | ||
| Synergistic cytotoxicity with 2'-deoxy-5-azacytidine and topotecan in vitro and in vivo | Q41092033 | ||
| Characterization of epithelial phenotypes in mortal and immortal human breast cells | Q41642211 | ||
| CpG island methylator phenotype is an independent predictor of survival benefit from 5-fluorouracil in stage III colorectal cancer | Q44545555 | ||
| Prognostic importance of promoter hypermethylation of multiple genes in esophageal adenocarcinoma | Q44587417 | ||
| Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. | Q44615045 | ||
| Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors | Q45877410 | ||
| Complete genetic suppression of polyp formation and reduction of CpG-island hypermethylation in Apc(Min/+) Dnmt1-hypomorphic Mice. | Q46051010 | ||
| DNA methylation differences associated with tumor tissues identified by genome scanning analysis | Q46413490 | ||
| DNA methylation and environmental exposures in human hepatocellular carcinoma | Q46624423 | ||
| Fields of aberrant CpG island hypermethylation in Barrett's esophagus and associated adenocarcinoma. | Q46873710 | ||
| Mapping of ER gene CpG island methylation-specific polymerase chain reaction. | Q47945083 | ||
| Heterogeneous expression of the lipocalin NGAL in primary breast cancers. | Q55068164 | ||
| Molecular Portraits and 70-Gene Prognosis Signature Are Preserved throughout the Metastatic Process of Breast Cancer | Q59565565 | ||
| Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype | Q73163014 | ||
| Hypermethylation of multiple genes in pancreatic adenocarcinoma | Q73679019 | ||
| Hypermethylation of E-cadherin in leukemia | Q73783325 | ||
| Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia | Q78125085 | ||
| Promoter hypermethylation profile of kidney cancer | Q80242653 | ||
| Hypermethylation in histologically distinct classes of breast cancer | Q80787663 | ||
| Cancer epigenetics | Q81611376 | ||
| Identification of 20 genes aberrantly methylated in human breast cancers | Q81629206 | ||
| P921 | main subject | phenotype | Q104053 |
| breast cancer | Q128581 | ||
| overexpression | Q61643320 | ||
| P304 | page(s) | 15 | |
| P577 | publication date | 2008-01-25 | |
| P1433 | published in | Molecular Cancer | Q15724585 |
| P1476 | title | DNMT3b overexpression contributes to a hypermethylator phenotype in human breast cancer cell lines | |
| P478 | volume | 7 |
| Q35868661 | A comprehensive analysis of radiosensitization targets; functional inhibition of DNA methyltransferase 3B radiosensitizes by disrupting DNA damage regulation |
| Q36603339 | A regulatory circuit of miR-148a/152 and DNMT1 in modulating cell transformation and tumor angiogenesis through IGF-IR and IRS1. |
| Q33689442 | Array-Based DNA Methylation Profiling for Breast Cancer Subtype Discrimination |
| Q34709370 | Assessment of DNA methylation status in early stages of breast cancer development |
| Q35163988 | Body mass index is associated with gene methylation in estrogen receptor-positive breast tumors |
| Q27694164 | Breast cancer epigenetics: from DNA methylation to microRNAs |
| Q39136019 | Coordination of Cellular Localization-Dependent Effects of Sumoylation in Regulating Cardiovascular and Neurological Diseases |
| Q88313562 | Culturing conditions highly affect DNA methylation and gene expression levels in MCF7 breast cancer cell line |
| Q33816178 | DNA methylation profiling in doxorubicin treated primary locally advanced breast tumours identifies novel genes associated with survival and treatment response |
| Q35000317 | DNA methylation profiling in the Carolina Breast Cancer Study defines cancer subclasses differing in clinicopathologic characteristics and survival |
| Q39797958 | DNA methyltransferase expression differs with proliferation in childhood acute lymphoblastic leukemia |
| Q88511739 | DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine |
| Q33579896 | DNA methyltransferases: a novel target for prevention and therapy |
| Q36823294 | DNMT1 genetic polymorphisms affect breast cancer risk in the central European Caucasian population |
| Q50780991 | DNMT3A rs36012910 A>G polymorphism and gastric cancer susceptibility in a Chinese population. |
| Q89324790 | DNMT3B -579 G>T Promoter Polymorphism and the Risk of Gastric Cancer in the West of Iran |
| Q51565168 | DNMT3B -579 G>T promoter polymorphism and risk of gallbladder carcinoma in North Indian population. |
| Q33837632 | DNMT3B expression might contribute to CpG island methylator phenotype in colorectal cancer |
| Q39560130 | DNMT3B gene amplification predicts resistance to DNA demethylating drugs |
| Q37596825 | DNMT3B modulates the expression of cancer-related genes and downregulates the expression of the gene VAV3 via methylation. |
| Q38790387 | DNMT3b Modulates Melanoma Growth by Controlling Levels of mTORC2 Component RICTOR. |
| Q34299011 | De Novo DNA Methyltransferase DNMT3b Interacts with NEDD8-modified Proteins |
| Q38902837 | Deregulation of DNMT1, DNMT3B and miR-29s in Burkitt lymphoma suggests novel contribution for disease pathogenesis. |
| Q64894664 | Derivative of Stevioside; CPUK02; Restores ESR1 Gene Methylation in MDA-MB 231 |
| Q54287944 | Diet-induced hypoxia responsive element demethylation increases CEACAM6 expression, favouring Crohn's disease-associated Escherichia coli colonisation. |
| Q35760936 | Distinct roles of DNMT1-dependent and DNMT1-independent methylation patterns in the genome of mouse embryonic stem cells |
| Q38926909 | Disturbed Flow-Induced Endothelial Proatherogenic Signaling Via Regulating Post-Translational Modifications and Epigenetic Events |
| Q37503958 | Dysregulation of microRNA expression drives aberrant DNA hypermethylation in basal-like breast cancer. |
| Q42444996 | Dysregulation of the epigenome in triple-negative breast cancers: basal-like and claudin-low breast cancers express aberrant DNA hypermethylation |
| Q39747936 | ERalpha signaling through slug regulates E-cadherin and EMT. |
| Q37190494 | ERα propelled aberrant global DNA hypermethylation by activating the DNMT1 gene to enhance anticancer drug resistance in human breast cancer cells |
| Q39639196 | Effects of specific DNMT gene depletion on cancer cell transformation and breast cancer cell invasion; toward selective DNMT inhibitors |
| Q41871991 | Electrochemical assay for the signal-on detection of human DNA methyltransferase activity |
| Q39584485 | Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b |
| Q24629061 | Epigenetic control of the basal-like gene expression profile via Interleukin-6 in breast cancer cells |
| Q28385417 | Epigenetic effects of endocrine-disrupting chemicals on female reproduction: an ovarian perspective |
| Q90428496 | Epigenetic engineering of yeast reveals dynamic molecular adaptation to methylation stress and genetic modulators of specific DNMT3 family members |
| Q36012682 | Epigenetic reprogramming of cancer cells via targeted DNA methylation. |
| Q35034068 | Epigenetic silencing of erythropoietin in human cancers |
| Q92917105 | Epigenetics of Breast Cancer: Clinical Status of Epi-drugs and Phytochemicals |
| Q38012175 | Epigenetics of estrogen receptor-negative primary breast cancer |
| Q37078784 | Epigenomics and breast cancer |
| Q37092668 | Exposure to estrogen and ionizing radiation causes epigenetic dysregulation, activation of mitogen-activated protein kinase pathways, and genome instability in the mammary gland of ACI rats |
| Q39031283 | Expression of myeloperoxidase in acute myeloid leukemia blasts mirrors the distinct DNA methylation pattern involving the downregulation of DNA methyltransferase DNMT3B. |
| Q37369129 | Fetal and neonatal exposure to the endocrine disruptor methoxychlor causes epigenetic alterations in adult ovarian genes |
| Q36106731 | FoxM1 regulates mammary luminal cell fate |
| Q39827986 | Generation of an epigenetic signature by chronic hypoxia in prostate cells |
| Q42175459 | Genome-wide DNA methylation sequencing reveals miR-663a is a novel epimutation candidate in CIMP-high endometrial cancer |
| Q39430136 | Genome-wide methylation analysis of DNMT3B gene isoforms revealed specific methylation profiles in breast cell lines |
| Q35113247 | Hierarchical clustering of breast cancer methylomes revealed differentially methylated and expressed breast cancer genes. |
| Q34974989 | Hypermethylation of multiple tumor-related genes associated with DNMT3b up-regulation served as a biomarker for early diagnosis of esophageal squamous cell carcinoma |
| Q39707882 | Hypermethylation of the progesterone receptor A in constitutive antiprogestin-resistant mouse mammary carcinomas. |
| Q33818726 | Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma |
| Q35911242 | Increased DNA methyltransferase activity and DNA methylation following Epidermal Growth Factor stimulation in ovarian cancer cells |
| Q37569819 | Induction of Epigenetic Alteration by CPUK02, An Ent- kaurenoid Derivative of Stevioside. |
| Q61814607 | Interplay between Epigenetics, Expression of Estrogen Receptor- α, HER2/ERBB2 and Sensitivity of Triple Negative Breast Cancer Cells to Hormonal Therapy |
| Q46618175 | Intragenic DNA methylation and BORIS-mediated cancer-specific splicing contribute to the Warburg effect |
| Q33828527 | Investigating the potential role of genetic and epigenetic variation of DNA methyltransferase genes in hyperplastic polyposis syndrome |
| Q36070908 | Involvement of DNMT 3B promotes epithelial-mesenchymal transition and gene expression profile of invasive head and neck squamous cell carcinomas cell lines |
| Q37696405 | Loss of post-transcriptional regulation of DNMT3b by microRNAs: a possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines |
| Q39475906 | MTSS1, a novel target of DNA methyltransferase 3B, functions as a tumor suppressor in hepatocellular carcinoma |
| Q33974223 | Mechanisms of epigenetic silencing of the Rassf1a gene during estrogen-induced breast carcinogenesis in ACI rats |
| Q42325823 | Meta-analysis Reveals No Association of DNMT3B -149 C>T Gene Polymorphism With Overall Cancer Risk. |
| Q44940375 | Methylation of miR-124a-1, miR-124a-2, and miR-124a-3 genes correlates with aggressive and advanced breast cancer disease |
| Q39003299 | Methylation status of homeobox genes in common human cancers |
| Q40522662 | MiR-339 and especially miR-766 reactivate the expression of tumor suppressor genes in colorectal cancer cell lines through DNA methyltransferase 3B gene inhibition. |
| Q24645663 | MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer |
| Q26742136 | Modifiers and Readers of DNA Modifications and Their Impact on Genome Structure, Expression, and Stability in Disease |
| Q35833292 | Molecular Subtype-Specific Expression of MicroRNA-29c in Breast Cancer Is Associated with CpG Dinucleotide Methylation of the Promoter |
| Q37360417 | Multifunctional Cu2-xTe Nanocubes Mediated Combination Therapy for Multi-Drug Resistant MDA MB 453. |
| Q35781542 | Ndrg2 promoter hypermethylation triggered by helicobacter pylori infection correlates with poor patients survival in human gastric carcinoma |
| Q34411880 | Normal DNA methylation dynamics in DICER1-deficient mouse embryonic stem cells |
| Q37529397 | Oestrogen receptor negativity in breast cancer: a cause or consequence? |
| Q64063399 | Prognosis Prediction of Colorectal Cancer Using Gene Expression Profiles |
| Q34014559 | Promoter Methylation in Prostate Cancer and its Application for the Early Detection of Prostate Cancer Using Serum and Urine Samples |
| Q94554680 | Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21 |
| Q37102684 | Restoration of the methylation status of hypermethylated gene promoters by microRNA-29b in human breast cancer: A novel epigenetic therapeutic approach |
| Q57811252 | Single-nucleotide polymorphisms in DNMT3B gene and DNMT3B mRNA expression in association with prostate cancer mortality |
| Q36937053 | Sustained induction of epithelial to mesenchymal transition activates DNA methylation of genes silenced in basal-like breast cancers |
| Q39103683 | Synergistic anti-breast cancer effect of a combined treatment with the methyl donor S-adenosyl methionine and the DNA methylation inhibitor 5-aza-2'-deoxycytidine |
| Q93116743 | TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells |
| Q33755220 | TBX2 represses CST6 resulting in uncontrolled legumain activity to sustain breast cancer proliferation: a novel cancer-selective target pathway with therapeutic opportunities |
| Q59329522 | Targets and genomic constraints of ectopic Dnmt3b expression |
| Q45715256 | The 46359CT polymorphism of DNMT3B is associated with the risk of cervical cancer |
| Q57107038 | The Epigenetics of Triple-Negative and Basal-Like Breast Cancer: Current Knowledge |
| Q37181530 | The RNA-binding protein HuR regulates DNA methylation through stabilization of DNMT3b mRNA. |
| Q37911496 | The application of delivery systems for DNA methyltransferase inhibitors |
| Q42683890 | The construction of intrahepatic cholangiocarcinoma model in zebrafish |
| Q33718270 | The role of epigenetic transcription repression and DNA methyltransferases in cancer. |
| Q37603500 | miR-148a-3p represses proliferation and EMT by establishing regulatory circuits between ERBB3/AKT2/c-myc and DNMT1 in bladder cancer |
| Q55352295 | miR-29c plays a suppressive role in breast cancer by targeting the TIMP3/STAT1/FOXO1 pathway. |
Search more.